Clinical Trial Update: A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls [Phase 3]

View source ↗

Summary

Phase 3 bridging trial update for a recombinant HPV 16/18 bivalent vaccine in preadolescent girls; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Persistent Hpv Infection
• Vaginal Intraepithelial Neoplasia
• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• recombinant human papillomavirus 16/18 bivalent vaccine (HPV16/18 bivalent vaccine)

Snippet

Sponsor: Jun Zhang | Conditions: Cervical Intraepithelial Neoplasia, Cervical Cancer | Phase 3 | Status: COMPLETED